FDA successfully completed inspection of Derivados Quimicos sau

Infa Group is pleased to announce that the US Food and Drug Administration (FDA) has successfully completed the inspection of the Spanish active pharmaceutical ingredient (API) and intermediates manufacturing facility Derivados Quimicos. The FDA inspected Derivados Quimicos  from October 19 to 22, …

AIFA successfully completed inspection of Labochim

Infa Group is very pleased to announce that the Italian Health Authorities (AIFA) inspection of Labochim, has been successfully completed. AIFA inspected Labochim, one of Infa Group’s active pharmaceutical ingredient (API) manufacturing facilities, from May 25 to 29, 2015 and found the …

FDA successfully completed inspections of Sifavitor and Labochim

Infa Group is pleased to announce that the US Food and Drug Administration (FDA) successfully completed the inspections of both Italian active pharmaceutical ingredient (API) manufacturing facilities Sifavitor and Labochim. Both facilities and the quality systems used for the manufacture and release …